Key result
Glucocorticoid-responsive HSV vector driving Glut-1 reduces glutamatergic excitotoxicity in hippocampal cultures.
p-value: p=<0.001
A glucocorticoid-responsive herpes simplex virus vector can be induced by neurological insults to express neuroprotective transgenes and decrease excitotoxicity in preclinical models.
Preclinical neuroprotection data support testing glucocorticoid-inducible vectors in brain injury models; leaves open clinical translation.
Gene transfer into neurons via viral vectors for protection against acute necrotic insults has generated considerable interest. Most studies have used constitutive vector systems, limiting the ability to control transgene expression in a dose-dependent, time-dependent, or reversible manner. We have constructed defective herpes simplex virus vectors designed to be induced by necrotic neurological insults themselves. Such vectors contain a synthetic glucocorticoid-responsive promoter, taking advantage of the almost uniquely high levels of glucocorticoids-adrenal stress steroids-secreted in response to such insults. We observed dose-responsive and steroid-specific induction by endogenous and synthetic glucocorticoids in hippocampal cultures. Induction was likely to be rapid enough to allow transgenic manipulation of relatively early steps in the cascade of necrotic neuron death. The protective potential of such a vector was tested by inclusion of a neuroprotective transgene (the Glut-1 glucose transporter). Induction of this vector by glucocorticoids decreased glutamatergic excitotoxicity in culture. Finally, both exogenous glucocorticoids and excitotoxic seizures induced reporter gene expression driven from a glucocorticoid-responsive herpes simplex virus vector in the hippocampus in vivo.
No takes yet. Share an insight, caveat, or question.
Ozawa et al. (2000) studied Necrotic neurological insults (excitotoxicity). Glucocorticoid-responsive herpes simplex virus vector (vGRE(L)gtlacZ) vs. Control vector (vGRE(L)lacZ) or vehicle was evaluated on Glutamate-induced neuron death in culture (p=<0.001). A herpes simplex virus vector containing a glucocorticoid-responsive promoter driving the Glut-1 glucose transporter significantly decreased glutamatergic excitotoxicity in hippocampal cultures.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: